Estrada-Altamirano A, Chacón- Solís RA, Hernández-Pacheco JA, Belmont-Gómez A, Valenzuela-Jirón A, Carvajal-Valencia JA, Maya-Quiñones JL

Language: Spanish
References: 19
Page: 38-44
PDF size: 341.70 Kb.

ABSTRACT

We report the case of a 16 years old female patient, with a pregnancy history of 11.4 weeks by ultrasound and intrauterine fetal death. In a private clinic were prescribed methotrexate 500 mg intramuscular single dose, and vaginal misoprostol. She had a clinical feature of five days of evolution characterized by fever of 39 ºC, nausea, general attack and vomiting. The initial diagnosis was severe sepsis secondary to septic abortion, oral candidiasis and acute poisoning by methotrexate. After that, she was referred to the Instituto Nacional de Perinatología, where stayed with fever for four days, and was managed with hydration, antibiotics, folinic acid and alkalizing. Her recovery was gradual. She was discharged after 12 days with significant clinical improvement. The literature review describes that the use of methotrexate for abortion purpose with therapeutic-dose presents a similar adverse effects to those found in our patient, however there are no case reports that describe the use of this drug in macrodosis for the same purpose, and their cytotoxic effects. We present this case because the patient used a macrodosis of this antimetabolite and due to the premature and empirical management with folinic acid, joined with alkalinization of urine, is the ideal treatment and as it is illustrated in our case.

REFERENCES

1. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 94: Medical management of ectopic pregnancy. Obstet Gynecol 2008;111(6):1479-1485.

2. Barnhart KT, Gosman G, Ashby R, Sammel M. The medical management of ectopic pregnancy: a meta-analysis comparing “single dose” and “multidose” regimens. Obstet Gynecol 2003;101:778-784.

3. Gaviño GF, Ruiz CM, Salazar LOC, Sánchez SV, Ahued AJ. Experiencia inicial con un esquema de minidosis única de metotrexato para el manejo de embarazo ectópico no roto. Ginecol Obstet Mex 1999;67:234-237.

4. Creinin MD, Damey PD. Methotrexate and misoprostol for early abortion. Contraception 1993;48:339-348.

5. Wiebe ER. Abortion induced with methotrexate and misoprostol: a comparison of various protocols. Contraception 1997;55:159-163.

6. Creinin MD, Vittinghoff E, Galbraith S, Klaisle C. A randomized trial comparing misoprostol three days and seven after methotrexate for early abortion. Am J Obstet Gynecol 1995;173:1578- 1584.

7. Hausknecht RU. Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med 1995;333:337-340.

8. Wiebe ER. Abortion induced with methotrexate and misoprostol. CMAJ 1996;154:165-170.

9. Wiebe ER. Choosing between surgical abortions and medical abortions induced with methotrexate and misoprostol. Contraception 1997;55:67-71.

10. Creinin MD. Oral methotrexate and vaginal misoprostol for early abortion. Contraception 1996;54:321-327.

11. Creinin MD, Vittinghoff E, Schaff E, Klaisle C, et al. Medical abortion with oral methotrexate and vaginal misoprostol. Obstet Gynecol 1997;90:611-616.

12. Carbonell JL, Varela L, Velazco A, Cabezas E, et al. Oral methotrexate and vaginal misoprostol for early abortion. Contraception 1998;57:83-88.

13. Widemann BC, Adamson PC. Understanding and managing methotrexate nephrotoxicity. Oncologist 2006;11:694-703.

14. Christin-Maitre S, Bouchard P, Spitz IM. Medical termination of pregnancy. N Engl J Med 2000;342:946-956.

15. UNDP/UNFPA/WHO/World Bank Special Programme of Research Development and Research Training in Human Reproduction. Methotrexate for the termination of early pregnancy: a toxicology review. Reproductive Health Matters 1997;5(9):162-167.

16. Creinin MD, Krohn MA. Methotrexate pharmacokinetics and effects in women receiving methotrexate 50 mg and 60 mg per square meter for early abortion. Am J Obstet Gynecol 1997;177:1444-1449.

17. Relling MV, Fairclough D, Ayers D, Crom R, et al. Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J Clin Oncol 1994;8:1667-1672.

18. Fernández MJ, Almiñana MA, Terol Castera MJ. Manejo de la intoxicación por metotrexato: a propósito de un caso. Farm Hosp 2004;28:371-374.

19. Alfaro LJ, Von Mühlenbrock SR, Burgos SN, Valdés RE y col. Intoxicación aguda con metotrexato usado con fines abortivos: descripción de 2 casos. Rev Med Chile 2000;128(3).